Following the Food and Drug Administration's release of recommendations on limiting the use of products containing hexachlorophene (HCP) for bathing newborn infants, 142 hospitals spontaneously reported outbreaks of neonatal staphybococcal disease. Epidemiologic investigations were carried out in 73 of these hospitals; 66 had confirmed outbreaks of neonatal staphylococcal disease. In 60 of the 66, discontinuation of HCP bathing of newborn infants preceded the epidemic. Alterations in handwashing policies did not appear implicated in any outbreak investigated. These findings suggested that discontinuation of HCP bathing of newborn infants was associated with increased incidence of neonatal staphylococcal disease.

This content is only available via PDF.
You do not currently have access to this content.